News

These funds, which bear no interest, become repayable on the commercialization of C-Cure. The new funds, which have come from a range of new and existing investors, will

Before joining KineMatik, Mr Jarjour was vice president of global marketing at Organon. Previously, Mr Jarjour held key positions at top tier pharmaceutical organizations including Bristol-Myers Squibb, Pharmacia,

This initial safety study involves single injections of Protectan CBLB502 in ascending dose groups of six healthy volunteers each. Participants in the study are assessed for adverse side

This appointment, which represents a new position on the board, brings the total number of company directors to nine, with six serving independently. Current chairman Gregory Pusey is

Following an oral hearing, the opposition division of the European patent Office has announced its decision to revoke a European patent in its entirety. This patent, which is

Michael Lutz, global manager of Cogenics, said: “Our partnership with SinoGenoMax provides us with an established presence in China and an experienced international service partner who operates with

Mr Altig is the CFO at Pelican Life Sciences, a manufacturer of microbiological and molecularbiological consumables. Mr Altig has also served as a director of Optimer Pharmaceuticals since

Through the agreement, Hitachi Medical will market, sell and service the Hi Art system, which facilitates highly precise, computed tomography-guided radiation therapy for a wide range of clinical

Under the umbrella of Alliance HealthCare Services, the company’s imaging and oncology divisions will continue to operate under the names of Alliance Imaging and Alliance Oncology. The company